Response to MET inhibitors in patients with stage IV lung adenocarcinomas harboring MET mutations causing exon 14 skipping.
Cancer Discovery
Paik, Paul K PK; Drilon, Alexander A; Fan, Pang-Dian PD; Yu, Helena H; Rekhtman, Natasha N; Ginsberg, Michelle S MS; Borsu, Laetitia L; Schultz, Nikolaus N; Berger, Michael F MF; Rudin, Charles M CM; Ladanyi, Marc M